Home » Topics » Regulatory

Regulatory
RSS

FDA approves naloxegol for opioid-induced constipation in patients with chronic pain

Sep. 17, 2014

FDA approves Rixubis for children with hemophilia B

Sep. 16, 2014

FDA approves Contrave for chronic weight management

Sep. 12, 2014

New indication for Spiriva Respimat approved in Europe

Sep. 10, 2014

FDA awards pembrolizumab accelerated approval for melanoma

Sep. 5, 2014

FDA approves Vimpat as monotherapy for partial-onset seizures

Sep. 1, 2014

European Commission approves Bristol-Myers Squibb's Daklinza for HCV

Aug. 28, 2014

FDA approves Triumeq for HIV

Aug. 26, 2014

Apixaban granted FDA approval for DVT and PE

Aug. 22, 2014

Marketing approval granted for KRONUS ZnT8Ab ELISA Assay for diagnosis of type 1 diabetes

Aug. 21, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...